These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29456535)

  • 21. Pharmacological activation of liver X receptor during cigarette smoke exposure adversely affects alveolar macrophages and pulmonary surfactant homeostasis.
    Jubinville É; Routhier J; Maranda-Robitaille M; Pineault M; Milad N; Talbot M; Beaulieu MJ; Aubin S; Paré MÈ; Laplante M; Morissette MC
    Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L669-L678. PubMed ID: 30702343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
    Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
    Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of statins and the synthetic LXR agonist T0901317 on expression of ABCA1 transporter protein in human lung epithelial cell lines in vitro.
    He P; Smith A; Gelissen IC; Ammit AJ
    Pharmacol Rep; 2019 Dec; 71(6):1219-1226. PubMed ID: 31669886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
    Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
    Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits.
    Honzumi S; Shima A; Hiroshima A; Koieyama T; Terasaka N
    Biochim Biophys Acta; 2011 Dec; 1811(12):1136-45. PubMed ID: 21875689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
    Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling: A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS.
    Speen AM; Kim HH; Bauer RN; Meyer M; Gowdy KM; Fessler MB; Duncan KE; Liu W; Porter NA; Jaspers I
    J Biol Chem; 2016 Nov; 291(48):25192-25206. PubMed ID: 27703007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic cell-mimicking gold nanocages loaded with LXR agonist for attenuating the progression of murine systemic lupus erythematosus.
    Xu N; Li J; Gao Y; Zhou N; Ma Q; Wu M; Zhang Y; Sun X; Xie J; Shen G; Yang M; Tu Q; Xu X; Zhu J; Tao J
    Biomaterials; 2019 Mar; 197():380-392. PubMed ID: 30703743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Regulate Macrophage Polarization to Attenuate Systemic Lupus Erythematosus-Associated Diffuse Alveolar Hemorrhage in Mice.
    Chen X; Wei Q; Sun H; Zhang X; Yang C; Tao Y; Nong G
    Int J Stem Cells; 2021 Aug; 14(3):331-340. PubMed ID: 33906978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
    J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of notch enhances the anti-atherosclerotic effects of LXR agonists while reducing fatty liver development in ApoE-deficient mice.
    Hao Y; Wang X; Zhang F; Wang M; Wang Y; Wang H; Du Y; Wang T; Fu F; Gao Z; Zhang L
    Toxicol Appl Pharmacol; 2020 Nov; 406():115211. PubMed ID: 32853627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages.
    Ku CS; Park Y; Coleman SL; Lee J
    J Nutr Biochem; 2012 Oct; 23(10):1271-6. PubMed ID: 22209005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
    Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
    J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
    Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with TO901317, a synthetic liver X receptor agonist, reduces brain damage and attenuates neuroinflammation in experimental intracerebral hemorrhage.
    Wu CH; Chen CC; Lai CY; Hung TH; Lin CC; Chao M; Chen SF
    J Neuroinflammation; 2016 Mar; 13(1):62. PubMed ID: 26968836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.
    Ni J; Zhou LL; Ding L; Zhang XQ; Zhao X; Li H; Cao H; Liu S; Wang Z; Ma R; Wu J; Feng J
    Cancer Med; 2018 May; 7(5):1955-1966. PubMed ID: 29573196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol efflux is LXRα isoform-dependent in human macrophages.
    Ma AZ; Song ZY; Zhang Q
    BMC Cardiovasc Disord; 2014 Jul; 14():80. PubMed ID: 24996838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of liver X receptor induces macrophage interleukin-5 expression.
    Chen Y; Duan Y; Kang Y; Yang X; Jiang M; Zhang L; Li G; Yin Z; Hu W; Dong P; Li X; Hajjar DP; Han J
    J Biol Chem; 2012 Dec; 287(52):43340-50. PubMed ID: 23150660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of biological markers of liver X receptor (LXR) activation at the cell surface of human monocytes.
    Rébé C; Filomenko R; Raveneau M; Chevriaux A; Ishibashi M; Lagrost L; Junien JL; Gambert P; Masson D
    PLoS One; 2012; 7(11):e48738. PubMed ID: 23185273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of Liver X Receptor Has Potent Anti-HIV Effects in a Humanized Mouse Model of HIV Infection.
    Ramezani A; Dubrovsky L; Pushkarsky T; Sviridov D; Karandish S; Raj DS; Fitzgerald ML; Bukrinsky M
    J Pharmacol Exp Ther; 2015 Sep; 354(3):376-83. PubMed ID: 26126533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.